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ABSTRACT The tunicamycin biosynthetic gene cluster of Streptomyces chartreusis
consists of 14 genes (tunA to tunN) with a high degree of apparent translational
coupling. Transcriptional analysis revealed that all of these genes are likely to be
transcribed as a single operon from two promoters, tunp1 and tunp2. In-frame dele-
tion analysis revealed that just six of these genes (tunABCDEH) are essential for tuni-
camycin production in the heterologous host Streptomyces coelicolor, while ﬁve
(tunFGKLN) with likely counterparts in primary metabolism are not necessary, but
presumably ensure efﬁcient production of the antibiotic at the onset of tunicamycin
biosynthesis. Three genes are implicated in immunity, namely, tunI and tunJ, which
encode a two-component ABC transporter presumably required for export of the an-
tibiotic, and tunM, which encodes a putative S-adenosylmethionine (SAM)-dependent
methyltransferase. Expression of tunIJ or tunM in S. coelicolor conferred resistance to
exogenous tunicamycin. The results presented here provide new insights into tuni-
camycin biosynthesis and immunity.
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The tunicamycins are fatty acyl nucleoside antibiotics produced by severalactinomycetes, mostly Streptomyces species, including Streptomyces chartreusis
(1, 2). They consist of a unique 11-carbon core (tunicamine) decorated with uracil,
N-acetylglucosamine (GlcNAc), and variable fatty acyl moieties (Fig. 1). They are
potent inhibitors of cell wall biosynthesis in Gram-positive bacteria, where they
target MraY, which is required for the production of the peptidoglycan precursor
Lipid I (3, 4), and TarO, MnaA, and Cap5P, which are involved in teichoic acid
biosynthesis (5). They also inhibit protein N-glycosylation in eukaryotes (6), target-
ing dolichyl-phosphate alpha-N-acetyl-glucosaminyl-phosphotransferase (DPAGT1,
also known as GlcNAc-1-P transferase) and resulting in severe toxicity. While the
bacterial (e.g., MraY) and human (DPAGT1) targets are similar, in principle, it may be
possible to design tunicamycin variants that speciﬁcally inhibit the bacterial pro-
teins. A better understanding of tunicamycin biosynthesis and of the genes respon-
sible for the individual steps in its production could play an important role in the
delivery of such analogues. In an earlier work, we cloned and sequenced the
tunicamycin biosynthetic gene cluster (tun) from S. chartreusis, expressed it heter-
ologously in Streptomyces coelicolor, and proposed a biosynthetic pathway based
largely on homology of the encoded gene products with proteins of known
function (7). The cluster contains 14 genes, tunA to tunN, with many apparently
translationally coupled to the preceding gene (Fig. 1). Subsequent in vitro studies
of TunA and TunF combined with the deletion of tunB provided experimental
evidence for their speciﬁc roles in tunicamycin biosynthesis (8). Here, we report
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mutational analyses of the other 13 genes in the tun cluster, which, together with
transcriptional characterizations, provide new insights into tunicamycin biosynthe-
sis and immunity.
RESULTS
Transcriptional analysis of the tun gene cluster. Inspection of the tun gene
cluster (Fig. 1) revealed that of the 14 genes, 10 appeared to be translationally coupled
to the gene upstream. This, together with a maximal intergenic spacing of 39 bp,
suggested that the entire tun gene cluster might be expressed in a single operon. To
address this possibility, RNA was prepared from a lawn of S. coelicolorM1152 containing
the cloned tun gene cluster present on a 12.9-kb SacI fragment of pIJ12003a (7) and
used in reverse transcription (RT)-PCR experiments with primer pairs corresponding to
tun sequences located approximately 100 nt from the ends and beginnings of adjacent
genes (see Table S1 in the supplemental material). Ampliﬁcation of cDNA spanning
each of the gene junctions (Fig. 1) was indeed consistent with transcription of the tun
genes in a single operon.
To locate the potential transcriptional start site(s) of this likely tun operon, 5= rapid
ampliﬁcation of cDNA ends (RACE) experiments were carried out using the S. coelicolor
RNA preparation, and also RNA from S. chartreusis using ﬁve different primers, RACE1
to RACE5 (Table S1). Two putative transcriptional starts sites (tunp1 and tunp2) were
identiﬁed in RNA isolated from S. chartreusis and located within the SacI fragment; while
the tunp2 transcript was not observed in RNA from S. coelicolor/pIJ12003a, transcription
initiation at the promoter, aprp, of the apramycin resistance gene present in the cloning
vector was detected (Fig. 2). To assess whether these 5= transcript ends represented
promoter activity in vivo (as opposed to mRNA processing or degradation), PCR
fragments were generated that contained each individual putative promoter element,
inserted into the -glucuronidase reporter plasmid pGUS (9) and introduced into S.
coelicolor M1152. Growth on R5 agar containing the -glucosiduronic acid-derived
substrate X-gluc conﬁrmed promoter activity for tunp1 and aprp, but not for tunp2
FIG 1 (Top) Structures of the tunicamycins. (Bottom) The tunicamycin biosynthetic gene cluster, showing the size of the intergenic
regions (in bp) and the approximate location of the tun p1 and p2 promoters. The results of each of the reverse transcription
(RT)-PCRs are shown below the corresponding intergenic region. Left lane, pIJ12003a DNA template; center lane,RT; and right lane,
RT (control for DNA contamination).
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(Fig. 3), consistent with the lack of a detectable tunp2 transcript in S. coelicolor
M1152/pIJ12003a.
Antibiotic production in S. coelicolor under conditions of nitrogen limitation is
dependent on the intracellular signaling molecular ppGpp (10). To assess whether tun
FIG 2 Sequence of the tun promoter region showing the transcriptional start sites identiﬁed by 5= RACE. Putative 10 and 35 regions, where discernible, are
overscored in blue. The locations of the complementary primers used for 5= RACE are indicated beneath the sequence by red arrows. Nucleotides 1 to 100 are derived
from the cloning vector pRT802, used to construct pIJ12003a, and the SacI site at the end of the cloned tun gene fragment is shown in magenta. The N-terminal amino
acid sequence of TunA is shown in green. aprp, transcriptional start site of the apramycin resistance (apr) gene; p1 and p2, transcriptional start sites of the putative
tun operon.
FIG 3 (Top) Gus reporter assays on R5 agar of promoter fragments initiating transcription of the tun gene
cluster in S. coelicolorM1152 (negative, pGUS without an insert). Putative promoters contained within the
inserted PCR fragments are indicated by aprp (putative promoter of the apramycin resistance gene apr)
and p1 and p2, putative promoters of the likely tun operon. Gus activity results in the production of an
insoluble indigo-blue precipitate, which appears green on yellow R5 agar plates. (Bottom) Schematic
showing the relative positions of the three identiﬁed transcriptional start sites and the extent of the
sequences present in each inserted PCR fragment. aprp, transcriptional start site of the apramycin
resistance gene (apr); p1 and p2, transcriptional start sites of the putative tun operon.
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gene transcription was dependent on ppGpp, the same -glucuronidase promoter
fusions were introduced into S. coelicolor M145 and its ΔrelA mutant M571, and the
resulting exconjugants were assayed for promoter activity on supplemented minimal
medium solid (SMMS) agar containing X-gluc; no differences in promoter activity were
observed between the two strains (data not shown).
Deletion analysis of the tun gene cluster. Previous work showed that deletion of
tunB abolished tunicamycin production and provided new insights into its likely role in
tunicamycin biosynthesis (8).
To assess the validity of the rest of the proposed tunicamycin biosynthetic pathway,
in-frame deletion mutations were made by PCR-targeting for all 13 of the remaining
putative biosynthetic genes, and the mutated plasmid derivatives were introduced into
S. coelicolor M1152 by conjugation from Escherichia coli. The resulting strains were then
assayed for antimicrobial activity, using Bacillus subtilis EC1524 as an indicator strain
(Fig. 4). Individual deletion of tunACDEH abolished activity, while individual oblation of
tunFGK signiﬁcantly or markedly reduced it; mutations in tunLMN had no signiﬁcant
effects on the sizes of the zones of inhibition. Liquid chromatography-mass spectrom-
etry (LC-MS) analyses of culture supernatants obtained from the individual tunFGKLMN
mutants conﬁrmed retention of tunicamycin biosynthesis (very low for tunF), while
supernatants from the mutants lacking antimicrobial activity failed to show the typical
characteristic tunicamycin mass spectrum of the wild-type gene cluster (see reference
7; data not shown).
To conﬁrm that the loss of antibiotic production in the tunACDEH mutants and the
reduction in the tunFGK deletion strains reﬂected the in-frame deletion of individual
genes, and not polar effects on the expression of downstream genes, PCR fragments
containing each of the deleted genes were cloned individually in pIJ12551 (tunAC-
DEGHK) or in pSET152 (tunF) under the control of the constitutive ermE* promoter and
introduced into the S. coelicolor derivative containing the corresponding mutated tun
gene cluster. With the exception of tunA (see Discussion), antimicrobial activity against
B. subtilis was restored in the nonproducing strains and was markedly increased in the
tunFGK mutants (Fig. 4), conﬁrming that the loss or reduction of antibiotic activity did
indeed reﬂect the inactivation of individual genes.
FIG 4 Bioassays of S. coelicolor M1152 derivatives containing a mutated tun gene cluster together with the empty
vector pRT802 (left) or complementation construct (right). M1152 derivatives containing pIJ12003a or pRT802 as
positive and negative controls, respectively, are also shown (center bottom). N/A, not applicable.
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To identify possible biosynthetic intermediates, culture supernatants and acid ex-
tracts of the mycelia of the tunCDEH mutants were also assessed by mass spectrometry
for the production of the predicted biosynthetic intermediates that would be expected
to accumulate based on the proposed biosynthetic pathway. However, none of the
predicted molecular ions could be detected (data not shown). A comparative untar-
geted metabolomics analysis (11) of these strains also failed to show differential
accumulation in any of the mutants of any metabolites with masses compatible with
tunicamycin-related molecules.
An attempt was then made to identify the production of tunicamycin biosynthetic
intermediates by cross-feeding and coculture experiments, using all possible pairwise
combinations of mutants (including the tunB mutant) in which antibiotic activity had
been lost. Bioactivity was assessed by overlaying the cross-feeding and coculture plates
with a lawn of B. subtilis cells. In no case was antibiotic production restored (data not
shown).
Immunity to tunicamycin. In addition to making in-frame deletion mutations in the
tun genes thought to be involved in tunicamycin biosynthesis, we also attempted to
make similar mutations in tunIJ, encoding a putative ABC transporter and believed to
be required for export of the intracellular antibiotic. Attempts were made to make
in-frame deletions of tunIJ together and of each gene individually, and the effect of the
mutations on tunicamycin production was assessed as before, using B. subtilis EC1524
as the indicator strain. In contrast to the other tun gene mutations, exconjugants with
deletions of tunIJ or tunI took up to 2 weeks to emerge and were few in number.
When both genes were deleted simultaneously, two mutant phenotypes were
obtained, a marked reduction in antibiotic activity (the ΔtunIJ-A phenotype) and a
complete loss of activity (the ΔtunIJ-B phenotype). Introduction of pIJ12551::tunIJ into
each of the mutants had no signiﬁcant effect on their phenotypes (Fig. 5a).
Sequencing of the tun gene cluster in the ΔtunIJ-A mutant revealed insertion of a T
toward the end of tunG (immediately after the codon for aspartate 171 of the 203-
amino acid [aa] TunG) that would result in the production of a TunGH fusion protein.
While earlier deletion of tunG reduced tunicamycin production, mutation of tunH,
which encodes a putative UDP-tunicaminyl-uracil pyrophosphatase, abolished it. Thus,
the frameshift mutation may have resulted in a fusion protein with little or no TunH
activity and may have also markedly reduced or abolished translation initiation at the
natural tunH start codon, thus resulting in markedly reduced levels of tunicamycin
production.
Sequencing of the tun gene cluster in the ΔtunIJ-B mutant revealed a frameshift
mutation in tunD, which is predicted to encode the glycosyltransferase required for
addition of an N-acetylglucosamine moiety to tunicaminyl-uracil. The insertion of a G after
the codon for threonine 279, while leaving glycine 280 and proline 281 unchanged, would
replace the C-terminal 191-aa residues of the 472-aa TunD protein with 107 residues of
presumably nonfunctional protein (see Fig. S1 in the supplemental material), likely account-
ing for the lack of bioactivity and failure to complement the mutation.
In-frame deletion of tunI alone yielded the same two mutant phenotypes (A and B,
marked reduction in and complete loss of antibiotic activity, respectively) observed as
when tunI and tunJ were deleted simultaneously; introduction of pIJ12551::tunI into
each of the mutants had no signiﬁcant effect on their phenotypes (Fig. 5b). Sequencing
of the tun gene cluster in the tunI-A mutant revealed a single nucleotide change, a T
to C transition found four nucleotides upstream of the GTG start codon of tunA. To
conﬁrm that this mutation was indeed responsible for the low level of antibiotic
activity, this same mutation was introduced into pIJ12003a by replacing the 2.4-kb
SacI-StuI region of the wild-type tun gene cluster with a PCR fragment generated from
the mutated plasmid. The resulting construct (pBDW177) was conﬁrmed by sequencing
and introduced into S. coelicolor M1152, whereupon it gave the same phenotype as the
tunI-A mutant, i.e., a much-reduced level of antimicrobial activity (see Fig. S2 in the
supplemental material). Sequencing of the tun gene cluster in the ΔtunI-B mutant
Tunicamycin Biosynthesis and Immunity Antimicrobial Agents and Chemotherapy
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revealed a G to A missense mutation in tunC that would result in a Gly to Asp
substitution at position 70 of the putative 318-aa N-acyltransferase, presumably result-
ing in loss of enzyme function and lack of tunicamycin production.
In-frame deletion of tunJ alone resulted in loss of antibiotic production that could
not be complemented by introduction of pIJ12551::tunJ (Fig. 5c); subsequent sequenc-
ing of the tun gene cluster in two of these possibly clonal mutants revealed the
insertion of a copy of IS10 toward the end of tunD (one nucleotide after the codon for
glycine 436 of TunD) that must have occurred when pIJ12003a was passaged through
E. coli for mutant construction. Insertion of IS10 occurred after nucleotide 12871 of
GenBank accession number HQ172897 and resulted in the duplication of residues
FIG 5 Bioassays of agar plugs of S. coelicolor M1152 containing the wild-type tun gene cluster
(pIJ12003a), and failed attempts to complement the tunIJ, tunI, and tunJ mutants with wild-type versions
of the deleted gene(s). In each case, B. subtilis EC1524 was used as the indicator strain. pIJ12551, the
empty vector used in the complementation experiments. In panel B, note that while the pIJ12003a
ΔtunI-A mutant clone generally gave a small zone of inhibition (see Fig. S2 in the supplemental material),
it failed to do so in this particular assay.
Widdick et al. Antimicrobial Agents and Chemotherapy
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12863 to 12871. The time taken for the emergence of the S. coelicolor M1152 excon-
jugants containing the tunJ deletion was normal for an E. coli-Streptomyces conjugation,
in contrast to the prolonged period required for emergence of the tunI suppressor
mutants, and was consistent with insertion of IS10 into tunD in E. coli.
In all ﬁve cases, the unexpected mutations were presumably not only responsible for
the lack of bioactivity, but also for the failure to complement the tunIJ mutants with
wild-type copies of the genes.
Both tunIJ and tunM confer immunity to tunicamycin in S. coelicolor. The results
obtained above suggested that in addition to playing a role in the export of tunicamycin,
tunIJ also played a role in conferring immunity to the antibiotic in the producing organism,
and that their deletion resulted in lethality or the selection of mutations that abolished or
markedly reduced the level of tunicamycin production. To assess the potential role of these
genes in immunity, S. coelicolor derivatives containing the wild-type tun gene cluster and
derivatives from which tunIJ, tunK, tunL, tunM, or tunN had been deleted were plated as
lawns on R5 agar, and their susceptibility to tunicamycin was assessed. While the wild-type
gene cluster conferred complete immunity to exogenous tunicamycin, deletion of tunIJ
and, surprisingly, of tunL and tunM, resulted in increased sensitivity, although all three
deletion mutants were noticeably more resistant than the strain containing the empty
vector (pRT802) (Fig. 6a). Deletion of tunK or tunN had no effect on susceptibility to
tunicamycin.
To assess whether expression of tunIJ, tunL, or tunM alone could confer immunity to
tunicamycin in S. coelicolor, the pIJ12551 expression constructs containing each of the
genes that had been used in the earlier complementation assays were introduced into
S. coelicolor M1152 by conjugation, and the resulting strains were used in tunicamycin
susceptibility assays. Expression of either tunIJ or tunM from the ermE* promoter
conferred complete immunity, while expression of tunL resulted in the same level of
susceptibility as that of the vector control (Fig. 6b). We therefore assume that the
enhanced susceptibility to tunicamycin shown by the tunL deletion mutant observed
above reﬂected a polar effect on tunM expression.
DISCUSSION
Although the presence of promoter elements within the cluster cannot be excluded,
the results presented in this paper suggest that all of the genes in the tunicamycin
biosynthetic gene cluster are cotranscribed in S. chartreusis from two promoters, one of
which, tunp2, is not utilized in S. coelicolor. The latter presumably reﬂects elements of
regulation that are missing in the heterologous host or the absence of cis-acting
regulatory sequences upstream of tunp2 in the cloned SacI fragment that are required
for its activation. With the exception of the 5= tunA, all of the genes required for
wild-type levels of tunicamycin biosynthesis appear to be translationally coupled to the
preceding gene. It is conceivable that such an arrangement ensures near stoichiometric
production of each of the corresponding proteins, which, interestingly, would be
consistent with the production of a large multifunctional enzyme complex. Given that
tunIJ also exhibit this coupling, it is also conceivable that such a complex could be
located at the cell membrane. Its existence would also be consistent with the inability
to detect biosynthetic intermediates predicted to accumulate in the tunCDEH mutants
either by mass spectrometry analysis or by cross-feeding, i.e., the lack of any one
component could result in inactivation of the entire complex (or indeed of a subcom-
plex).
Repeated attempts to complement the tunA mutant using both the ermE* and
native tunA promoter (data not shown) failed. Similar observations were made for
mibA, the 5= gene in a polycistronic mRNA that is essential for microbisporicin
biosynthesis in Microbispora corallina (Lucy Foulston, personal communication). It is
conceivable that this reﬂects an essential element of posttranscriptional control
that operates on the 5= end of the tun operon transcript that is absent in the tunA
deletion mutant.
The deletion analysis reported here and previously (8) has demonstrated that of the
Tunicamycin Biosynthesis and Immunity Antimicrobial Agents and Chemotherapy
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14 genes contained within the tun gene cluster just six (tunABCDEH) are essential for
tunicamycin production in S. coelicolor, each of which can be assigned a likely biosyn-
thetic role Fig. 7) (7, 8), while tunI and tunJ are required for immunity. Of the others,
tunFGKLN all have putative roles also carried out by homologues involved in primary
metabolism, potentially explaining their nonessentiality. This would require that the
primary metabolic enzymes were capable of substituting for their Tun counterparts if
the latter were indeed present in the hypothetical tunicamycin biosynthetic complex
(see above); alternatively, the complex might only contain the essential enzymes,
TunABCDEH. The presence of tunFGKLN within the tun gene cluster may be to ensure
adequate precursor supply and/or ﬂux at the onset of tunicamycin production, feeding
the likely critical C-C bond-forming step (tunFGN) and efﬁcient acylation from the
endogenous fatty acid pool during biosynthesis (tunKL) (see Fig. 7 and references 7, 8
for a detailed discussion of tunicamycin biosynthesis). Indeed, deletion of tunF, tunG, or
tunK resulted in a reproducible reduction in antibiotic activity (Fig. 4). The ability of the
tunL mutant clone to produce tunicamycin in S. coelicolor M1152 contrasts with the
results reported by Chen et al. (12), where tunicamycin production was abolished
when a tunL-deleted gene cluster was introduced into Streptomyces lividans TK24.
However, since TunL is a putative phospholipid phosphatase with homologues
FIG 6 Assays of sensitivity to tunicamycin. (a) Filter paper discs containing 0 or 75 g tunicamycin were
laid on top of lawns of spores of S. coelicolorM1152 derivatives containing the wild-type tun gene cluster
(pIJ12003a) and various deleted versions. Deletion of tunIJ, tunL, or tunM resulted in increased sensitivity
to tunicamycin. (b) Filter paper discs containing 0, 7.5, or 75 g tunicamycin were laid on top of lawns
of spores of S. coelicolor M1152 derivatives containing the ermE*p expression vector pIJ12551 or
derivatives thereof containing tunIJ, tunM, or tunL. In both sets of assays, R5 agar was used, and the plates
were incubated at 30°C for 48 h.
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encoded by the S. coelicolor genome (e.g., SCO1102 and SCO0402) that are likely
involved in primary metabolism, it is conceivable that this disparity reﬂects differ-
ences in the heterologous hosts and growth conditions used in the two studies.
Given the very low level of tunicamycin production in the tunF mutant, it is also
possible that a homologous host epimerase (e.g., SCO3137 and/or SCO2988) is
responsible for partial suppression of tunF oblation. The deletion analysis reported
here rules out the previously assigned role for TunM in tunicamycin biosynthesis (8).
However, the ability of tunM to confer resistance to tunicamycin in S. coelicolor, and
the increased levels of tunicamycin susceptibility observed after deletion of tunM
from the tun gene cluster in S. coelicolor, suggest that it may instead play a role in
immunity in the producing organism. Intriguingly, TunM encodes a putative SAM-
dependent methyltransferase and, although unprecedented to our knowledge, it is
conceivable that it mediates its effect by modiﬁcation of intracellular tunicamycin
to provide an immunity mechanism, although such a nonreversible modiﬁcation
would require a corresponding demethylation for activation, perhaps after export.
Conceivably, such demethylation enzymes might exist in the natural host’s key
target organisms. Alternatively, self-resistance might be mediated by methylation
of endogenous enzyme (or other molecular) targets of the antibiotic (or indeed by
modiﬁcation of one of their substrates in a manner that would afford sufﬁcient
substrate protection to prevent tunicamycin from binding to any corresponding
complex).
FIG 7 Proposed pathway for tunicamycin biosynthesis. tun gene products essential for tunicamycin production are circled in red and
nonessential proteins in green.
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MATERIALS AND METHODS
Strains and general methods. The strains used in this study are listed in Table 1. Escherichia coli
strains were grown and manipulated following standard methods (14, 23), with E. coli DH5 (15) used as
the general cloning host. Bacillus subtilis EC1524 (13) was grown in Luria Bertani broth (23). Streptomyces
strains were grown and manipulated as described previously (7, 24). Plasmids and oligonucleotides are
described in Tables 1 and S1, respectively. Tunicamycin was obtained from Abcam Biochemicals and
dissolved in 100% dimethyl sulfoxide (DMSO) at a concentration of 5 mg/ml prior to use.
Transcriptional analysis. RNA was prepared from lawns of mycelium approximately 30 mm in
diameter of S. coelicolor M1152/pIJ12003a and S. chartreusis cells grown for 2 days on R5 and DNA agar
(18, 24), respectively, using a bead-beater and a Qiagen RNeasy kit (Qiagen, Crawley, United Kingdom).
RT-PCR analysis was carried out on the S. coelicolor RNA sample; cDNA was prepared using a Qiagen
reverse transcription kit (Qiagen, Crawley, United Kingdom) and subjected to PCR, using the primer pairs
listed in Table S1. pIJ12003a was used as a positive control, and RNA that had not been treated with
reverse transcriptase was used as a negative control. The 5= ends of the tun transcripts present in both
RNA samples were identiﬁed by using a 5= rapid ampliﬁcation of cDNA ends (RACE) kit (version 2.0;
Invitrogen, Paisley, United Kingdom) following the manufacturer’s instructions. Brieﬂy, ﬁrst-strand cDNA
synthesis was carried out using 5 g of RNA, reverse transcriptase and the oligonucleotide primer RACE1
(Table S1). cDNA was puriﬁed using the SNAP columns provided in the kit, and poly(dC) tails were added
TABLE 1 Strains and plasmids used and/or created in this study
Strain or plasmid Description Reference and/or source
Strains
B. subtilis EC1524 Bioassay strain 13
E. coli BW25113/pIJ790 E. coli containing  Red plasmid 14
E. coli DH5 General cloning host 15
E. coli BT340 FLP recombinase strain 14
E. coli ET12567/pUZ8002 Conjugation of plasmids into S. coelicolor M1152 16
E. coli ET12567/pR9406 Conjugation of plasmids into S. coelicolor M1152 17; David Figurski, personal
communication
S. coelicolor M1152 Heterologous expression strain 18
Plasmids
pBlueScript II KS General cloning vector Agilent Technologies
pGUS -glucuronidase reporter plasmid 9
pIJ773 PCR template for apramycin resistance cassette 14
pIJ10257 BT1 integrative vector; used as source of ermE*p 19
pIJ12003a pRT802 containing the tun cluster on a 12.9 kb SacI fragment 7
pIJ12541 pIJ12003a with tunB deleted 8
pIJ12551 C31 integrative expression vector with ermE* promoter 20
pRT802 BT1 integrative vector 21
pSET152 C31 integrative vector 22
pBDW91 Effectively pIJ12003a with tunA deleted This study
pBDW92 Effectively pIJ12003a with tunC deleted This study
pBDW36 Effectively pIJ12003a with tunD deleted This study
pBDW37 Effectively pIJ12003a with tunE deleted This study
pIJ12542 pIJ12003a with tunF deleted This study
pBDW38 Effectively pIJ12003a with tunG deleted This study
pBDW39 Effectively pIJ12003a with tunH deleted This study
pBDW40 Effectively pIJ12003a with tunI deleted This study
pBDW41 Effectively pIJ12003a with tunJ deleted This study
pBDW42 Effectively pIJ12003a with tunIJ deleted This study
pBDW43 Effectively pIJ12003a with tunK deleted This study
pBDW44 Effectively pIJ12003a with tunL deleted This study
pBDW45 Effectively pIJ12003a with tunM deleted This study
pBDW46 Effectively pIJ12003a with tunN deleted This study
pBDW58 pIJ12551 tunA complementation construct This study
pBDW59 pIJ12551 tunC complementation construct This study
pBDW60 pIJ12551 tunD complementation construct This study
pBDW61 pIJ12551 tunE complementation construct This study
pIJ12544 pSET152 ermE*p::tunF complementation construct This study
pBDW62 pIJ12551 tunG complementation construct This study
pBDW65 pIJ12551 tunH complementation construct This study
pBDW66 pIJ12551 tunIJ complementation construct This study
pBDW155 pIJ12551 tunK complementation construct This study
pBDW132 pIJ12551 tunL complementation construct This study
pBDW133 pIJ12551 tunM complementation construct This study
pBDW177 pIJ12003a carrying the tunI-A mutation in tunA This study
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to the 3= ends using terminal deoxynucleotidyl transferase. PCR ampliﬁcation of the tailed cDNA was
initially carried out using the 5 = RACE abridged anchor primer with the ﬁrst-strand primer RACE2 or
RACE4 (Table S1). A dilution of the PCR mixture was then subjected to a second ampliﬁcation using the
abridged anchor primer with the second nested primer RACE3 or RACE5 (Table S1). The PCR product was
gel-puriﬁed and a portion sequenced directly using the oligonucleotide RACE3 or RACE5 as primer.
Gus assays. The DNA fragments to be assessed for promoter activity were cloned individually as
XbaI-KpnI PCR fragments in pGUS (9) and cleaved with the same two restriction enzymes, and the
resulting constructs were introduced into S. coelicolor M1152, M145, and M571 (ΔrelA mutant of M145;
see reference 25) by conjugation, whereupon they integrated at the chromosomal C31 attB sites of each
strain. The ability of the cloned fragments to direct transcription of the uidA gene encoding
-glucuronidase (Gus) was determined by plating the exconjugants on R5 and SMMS agar medium (24)
containing 0.16 mg/ml X-gluc (5-bromo-4-chloro-1H-indol-3-yl beta-D-glucopyranosiduronic acid) (cyc-
lohexylammonium salt; Gold Biotechnology).
Construction of deletion mutants. To construct the tunACDEGHIJKLMN mutants, the 12.9-kb SacI
fragment of pIJ12003a, a derivative of pRT802 (21), was ﬁrst subcloned into pBlueScript II KS to give
pBDW7. Gene deletions were made using the method of Gust et al. (2003) (14) by targeting pBDW7 with
apramycin resistance gene (apr) replacement cassettes generated using the PCR primers listed in Table
S1 and pIJ773 as the template DNA, and the cassettes were subsequently deleted using FLP recombinase
to give in-frame deletion mutants; in all cases, the ribosome-binding site of the downstream gene was
retained in the mutant construct. The SacI fragments from the resulting plasmids were subcloned into
pRT802, and those with the fragment inserted in the same orientation as in pIJ12003a (determined by
restriction enzyme digestion) were selected for further study. To construct the tunF mutant, pIJ12003a
was targeted in the same manner (see Table S1 for the primers used) to yield the mutant derivative
pIJ12542. Each of the mutated plasmids was introduced into E. coli ET12567/pR906 (17; David Figurski,
personal communication) by transformation and then into S. coelicolor M1152 by conjugation.
Complementation of deletion mutants. A PCR fragment was generated for selected deleted tun
genes using the primers in Table S1, pIJ12003a DNA as the template, and Phusion High Fidelity DNA
polymerase (New England BioLabs Inc.). The PCR products for tunACDEGHIJK were cleaved with NdeI and
PacI and inserted into pIJ12251 (20) cut with the same restriction enzymes. The PCR product for tunF was
cleaved with NdeI and HindIII and inserted downstream of the ermE* promoter of pIJ10257 (19) that had
been cut with the same restriction enzymes. The resulting plasmid was digested with BamHI and EcoRI
and the ermE*p::tunF fragment ligated into pSET152 (22) that had been similarly treated to give pIJ12544.
All of the individual complementation constructs, which were conﬁrmed by DNA sequencing, were
introduced into E. coli ET12567/pUZ8002 (16) by transformation and then into the appropriate S.
coelicolor deletion strain by conjugation.
Bioassays for tunicamycin production. Lawns of the strains to be assayed were made by spreading
approximately 107 spores in 100 l of water on R5 agar plates, followed by incubation at 30°C for 48 h.
Soft nutrient agar (SNA) was melted, cooled to 55°C, and inoculated with a one-tenth volume of a
mid-logarithmic growth culture of B. subtilis EC1524. Cylindrical plugs (approximately 8 mm in diameter)
were cut from the Streptomyces lawns using a cork borer and were either set into or laid on top of 40
ml of the SNA inoculated with B. subtilis EC1524 in a 10-cm2 plastic petri dish, which was then incubated
overnight at 30°C.
Analysis of immunity to tunicamycin. Lawns of the strains to be assayed were made by spreading
approximately 107 spores in 100 l of water onto R5 plates, which were allowed to dry for 20 min. Filter
paper discs with various amounts of tunicamycin (dissolved in DMSO) were laid onto the lawns, and the
plates were incubated at 30°C for 48 h.
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